AnGes, Inc.
AnGes, Inc. scores highest on Anchor (25) and lowest on Price (0). Its PosiPenta is 11.39 out of 100, clearly weaker than most similar companies.
On the Penta Grid this week, AnGes, Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,059 of 1,059 in Japan.
Compared with similar companies in the Healthcare sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| AnGes, Inc. | 11.39 | 0 | 22 | 6 | 4 | 25 |
| Ohki Healthcare Holdings Co.,Ltd. | 46.77 | 69 | 50 | 24 | 29 | 61 |
| StemRIM | 28.11 | 27 | 23 | 6 | 54 | 31 |
| Morishita Jintan Co., Ltd. | 70.43 | 84 | 84 | 68 | 50 | 66 |
| Create Medic Co., Ltd. | 61.79 | 67 | 53 | 79 | 51 | 59 |
| HYUGA PRIMARY CARE Co.,Ltd. | 56.04 | 17 | 65 | 100 | 56 | 43 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -3.15 |
| P/B ratio | 56.23 |
EEarnings
| Trailing EPS | ₹-5.58 |
| Forward EPS | — |
NNitro
| Price | 17.56 |
| 52-week high | 56.30 |
| 52-week low | 16.95 |
| Fall from 52-week high | 68.8% |
TTorque
| Return on equity (ROE) | -214.64% |
| Debt-to-equity | 3.52 |
AAnchor
| Beta (price swings) | 0.57 |
| Market cap | ₹700 Cr |
| Insider holding | 8.10% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is AnGes, Inc.'s PosiPenta score?
AnGes, Inc.'s PosiPenta is 11.39 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does AnGes, Inc. stand on the Penta Grid?
On the Penta Grid this week, AnGes, Inc. is Grid #53 of 53 in the Healthcare sector in Japan, and Grid #1,059 of 1,059 in Japan.
Which PosiPenta pillar is strongest for AnGes, Inc.?
Anchor (stability and dividends), with a score of 25 out of 100: weaker than most similar companies.
Which PosiPenta pillar is weakest for AnGes, Inc.?
Price (valuation), with a score of 0 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.